Thursday, November 21, 2024 11/21/2024

Recovery Management Checkup for Primary Care (RMC-PC) vs. Screening Brief Intervention and Referral to Treatment (SBIRT) Experiment

Award Number: R01AA024440
ORGANIZATION: NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Abstract

DESCRIPTION (provided by applicant): Screening and Brief Intervention (SBI) for risky adult alcohol use consistently identifies 5-10% of patients in need of brief intervention and 2-5% in need of more formal alcohol treatment. SBI programs are often expanded to include Referral to Treatment (aka SBIRT) to address the latter patients' needs and in primary care have increased access to treatment by 15-20% via referrals leaving 80-85% still needing treatment. Effective models of linking adults with SUD to AOD treatment are clearly needed. Recovery Management Checkups (RMC) are an effective strategy for linking individuals with SUDs to AOD treatment. In 3 trials, compared to the control group, RMC participants were significantly more likely to enter treatment, enter sooner, and stay longer, contributing to fewer days of substance use and fewer SUD symptoms. RMC was recently modified for primary care settings (RMC-PC) and piloted in Federally Qualified Health Centers (FQHC). Modifications include a primary care population presenting for physical health care (as opposed to AOD treatment), a refusal conversion component, telephone vs. face-to-face linkage, and referrals back to primary care when health problems are indicated. Results indicated that RMC-PC converted 75% of those who initially refused a referral for AOD treatment at the FQHC and quadrupled the linkage rate to treatment for these individuals. In the proposed trial, we will: a) recruit 300 adults needing AOD treatment at 4 FQHCs, b) randomly assign half to SBIRT and half to SBIRT+RMC-PC, and c) conduct quarterly follow-ups for 12-months. Hypotheses include: 1) Relative to the SBIRT patients, SBIRT+ RMC-PC patients will be more likely to: a) initiate AOD treatment sooner, b) receive any AOD treatment, and c) receive more days of AOD treatment; 2) Relative to the SBIRT patients, SBIRT+RMC-PC patients and those who get more AOD treatment will report less days of: a) alcohol use, b) heavy alcohol use, c) cannabis use, d) other drug use, and e) SUD problems; 3) days of treatment will mediate the relationship between SBIRT+RMC-PC and changes in the these AOD related behaviors; 4) Relative to the SBIRT patients, SBIRT+RMC-PC patients and those with fewer days of AOD use will have significantly less total health care utilization costs after factoring in increases in AOD treatment; 5) Days of AOD use will mediate the relationship between SBIRT+RMC-PC and total cost of health care utilization.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2022	CHESTNUT HEALTH SYSTEMS INC	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Alcohol Research Programs	000	5	1/23/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2022	CHESTNUT HEALTH SYSTEMS INC	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Alcohol Research Programs	000	5	11/30/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $353,928 )
2022	2022	CHESTNUT HEALTH SYSTEMS INC	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Alcohol Research Programs	001	5	6/20/2022	NON-COMPETING CONTINUATION	$35,393
2022	2022	CHESTNUT HEALTH SYSTEMS, INC.	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Alcohol Research Programs	000	5	12/29/2021	NON-COMPETING CONTINUATION	$318,535
														Subtotal = $353,928

Issue Date FY: 2021 ( Subtotal = $572,747 )
2021	2021	CHESTNUT HEALTH SYSTEMS, INC.	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Alcohol Research Programs	000	4	3/2/2021	NON-COMPETING CONTINUATION	$572,747
														Subtotal = $572,747

Issue Date FY: 2020 ( Subtotal = $576,464 )
2020	2020	CHESTNUT HEALTH SYSTEMS, INC.	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Alcohol Research Programs	001	3	4/2/2020	NON-COMPETING CONTINUATION	$57,647
2020	2020	CHESTNUT HEALTH SYSTEMS, INC.	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Alcohol Research Programs	000	3	12/24/2019	NON-COMPETING CONTINUATION	$518,817
														Subtotal = $576,464

Issue Date FY: 2019 ( Subtotal = $579,301 )
2019	2019	CHESTNUT HEALTH SYSTEMS, INC.	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Alcohol Research Programs	000	2	12/24/2018	NON-COMPETING CONTINUATION	$579,301
														Subtotal = $579,301

Issue Date FY: 2017 ( Subtotal = $538,957 )
2017	2017	CHESTNUT HEALTH SYSTEMS, INC.	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Alcohol Research Programs	000	1	1/27/2017	NEW	$538,957
														Subtotal = $538,957

Grand Total All Awards = $2,621,397

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Recovery Management Checkup for Primary Care (RMC-PC) vs. Screening Brief Intervention and Referral to Treatment (SBIRT) Experiment

Award Number: R01AA024440

ORGANIZATION: NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer